Psychoactive substances are chemical agents that alter brain function, resulting in temporary changes in perception, mood, consciousness, and behavior. Understanding these agents requires clear terminology to avoid clinical confusion and stigma.
In Nigerian clinical settings, nurses frequently encounter patients using both licit substances, like alcohol and prescription opioids, and illicit substances, such as cannabis and tramadol. Recognizing these basic definitions helps nurses document observations accurately and communicate effectively within the healthcare team.
Psychoactive substances exert their primary effects by interacting with the central nervous system, specifically altering neurotransmission at chemical synapses. Most drugs of abuse target the brain's reward pathway, involving the mesolimbic dopaminergic system which originates in the ventral tegmental area and projects to the nucleus accumbens.
When a psychoactive substance enters the brain, it can mimic natural neurotransmitters, block reuptake transporters, or stimulate excess release of chemical messengers like dopamine, serotonin, and gamma-aminobutyric acid. For example, stimulants such as amphetamines drive massive dopamine release, while depressants like alcohol enhance inhibitory gamma-aminobutyric acid activity. Repeated disruptions in these neural circuits lead to neuroadaptation, altering receptor density and intracellular signaling pathways. This biological remodeling underpins the compulsive drug-seeking behavior seen in chronic disorders.
Psychoactive substances are broadly categorized based on their primary pharmacological effects on the central nervous system.
| Category | Primary Effect | Common Examples |
|---|---|---|
| Depressants | Slow down brain activity and CNS function | Alcohol, benzodiazepines, barbiturates |
| Stimulants | Accelerate CNS activity and alertness | Cocaine, amphetamines, nicotine, caffeine |
| Hallucinogens | Alter perception, thought, and reality | LSD, psilocybin, ketamine |
| Cannabinoids | Produce mixed sedative and mild hallucinogenic effects | Cannabis, synthetic cannabinoids |
| Opioids | Relieve pain and induce euphoria | Morphine, heroin, tramadol, codeine |
Nurses must be familiar with these categories because clinical presentations vary widely. A patient experiencing stimulant toxicity will present with tachycardia and agitation, whereas a patient with depressant overdose will exhibit respiratory depression and sedation.
The transition from casual substance use to severe substance use disorder follows a predictable trajectory. Tolerance develops as cellular receptors desensitize, prompting the individual to increase doses. Dependence follows, characterized by neuroadaptation where the body cannot function normally without the substance.
When use abruptly stops, a withdrawal syndrome emerges, driven by rebound central nervous system hyperactivity in depressant withdrawal, or profound hypofunction in stimulant withdrawal. Alcohol and sedative withdrawal can lead to life-threatening complications such as delirium tremens and seizures, requiring urgent medical intervention. Opioid withdrawal, though intensely uncomfortable with severe muscle cramps, diarrhea, and vomiting, is rarely fatal on its own but carries high relapse risks due to psychological distress.
Routine screening allows nurses to identify substance misuse early before severe physical or mental complications develop. Validated screening tools streamline this process in busy clinical environments.
A thorough nursing assessment includes taking a detailed history regarding the type of substance, route of administration, frequency, timing of last use, and previous withdrawal episodes. Nurses must maintain a non-judgmental, empathetic attitude to encourage honest disclosure from patients who may fear legal consequences or social stigma.
Managing substance intoxication and withdrawal requires stabilizing vital signs, preventing physical injury, and addressing psychological distress. For acute intoxication, supportive care is the cornerstone: maintaining a patent airway, monitoring neurological status, and managing cardiovascular stability.
Pharmacological management is tailored to the specific substance. Benzodiazepines are the standard medical therapy for alcohol and sedative withdrawal to prevent seizures. For opioid withdrawal, agonist replacement therapies like methadone or alpha-2 adrenergic agonists such as clonidine help reduce autonomic symptoms. Non-pharmacological interventions include placing the patient in a quiet, low-stimulation environment, frequent orientation, and ensuring adequate hydration and nutrition. Nurses play a critical role in serial monitoring using validated scales like the Clinical Institute Withdrawal Assessment for Alcohol.
Comprehensive nursing care for individuals with substance use issues extends beyond acute physical stabilization to holistic rehabilitation and advocacy. A structured nursing care plan addresses immediate safety, coping mechanisms, and long-term relapse prevention.
Nursing diagnoses often include *Risk for Injury*, *Ineffective Coping*, and *Imbalanced Nutrition*. Interventions involve establishing therapeutic nurse-patient relationships, teaching stress-management techniques, and connecting patients with community support groups and rehabilitation services. Advocacy involves challenging stigmatizing attitudes among healthcare personnel, ensuring patients receive equitable medical treatment without prejudice, and protecting patient confidentiality within legal bounds.